Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271501 · ClinicalTrials.gov registry record · NA
Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions
A NA study, sponsored by Avita Medical.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04271501 is a NA study that was terminated before completion, run by Avita Medical. The registered enrollment target is 5 participants.
The verdict
NCT04271501, a NA study, was terminated before completion, sponsored by Avita Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.
Interventions
- PROCEDURE Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:5 and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:10 and Ultraviolet Lamp (UVB)
- DEVICE RECELL 1:20 and Ultraviolet Lamp (UVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2021-08-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04271501
The ClinicalTrials.gov registry entry for NCT04271501 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avita Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB) is the first listed.
NCT04271501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04271501 about?
NCT04271501 is a clinical study titled "Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions". Prospective randomized within-subject controlled feasibility study to evaluate the clinical performance of RECELL for repigmentation of stable, depigmented lesions. The trial will evaluate 50 matched, stable depigmented areas from 10 subjects.
What is the current status of trial NCT04271501?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2020-09-25. Estimated completion is 2021-08-24.
What interventions are being tested in trial NCT04271501?
The interventions under investigation include: Melanocyte-Keratinocyte Transplantation and Ultraviolet Lamp (UVB) (PROCEDURE), RECELL 1:5 and Ultraviolet Lamp (UVB) (DEVICE), RECELL 1:10 and Ultraviolet Lamp (UVB) (DEVICE), RECELL 1:20 and Ultraviolet Lamp (UVB) (DEVICE).
Who is sponsoring clinical trial NCT04271501?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.